The aurora kinases inhibitor VE-465 is a novel treatment for glioblastoma multiforme

Biochemistry, Genetics and Molecular Biology

• U87 100%
• Aurora Kinase 100%
• Protein Expression 50%
• Maturation 50%
• Small Molecule 50%
• Cell Cycle Regulation 50%
• IC50 50%
• Colony Formation 50%
• Polyploid 50%
• Cell Growth 50%
• P53 50%
• Caspase 50%
• Centrosome 50%

Neuroscience

• Glioblastoma Multiforme 100%
• Aurora Kinase 100%
• P53 9%
• Caspase 9%
• Protein Expression 9%
• Cell Line 9%
• Colony Formation 9%
• Polyploidy 9%
• Cell Cycle Regulation 9%
• Brain Tumor 9%
• Cell Growth 9%
• Centrosome 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Glioblastoma 100%
• Aurora Kinase Inhibitor 100%
• Chemotherapy 9%
• Protein P53 9%
• Brain Tumor 9%
• IC50 9%
• Caspase 9%